Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2021-01-26 Purchase | 2021-01-26 4:05 pm | Eidos Therapeutics Inc. | EIDX | BridgeBio Pharma Inc. 10% Owner | 14,428,836 | $0 | $0 | 1,000 (Direct) | View |
| 2021-01-13 Sale | 2021-01-15 4:05 pm | Eidos Therapeutics Inc. | EIDX | Sinha Uma Chief Scientific Officer | 10,000 | $124.32 | $1,243,179 | 306,525 (Direct) | View |
| 2021-01-11 Sale | 2021-01-13 4:05 pm | Eidos Therapeutics Inc. | EIDX | Valle Franco Senior Vice President, Finance | 3,247 | $125.52 | $407,560 | 50,447 (Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2021-01-26 Equity Swap | 2021-01-28 7:50 pm | N/A N/A | Eidos Therapeutics Inc. | EIDX | Fox Jonathan C See Remarks | 380,467 | $0 | 0 (Direct) | View |
| 2020-12-28 Gift | 2021-01-28 7:50 pm | N/A N/A | Eidos Therapeutics Inc. | EIDX | Fox Jonathan C See Remarks | 500 | $0 | 0 (Direct) | View |
| 2021-01-26 Equity Swap | 2021-01-28 7:15 pm | N/A N/A | Eidos Therapeutics Inc. | EIDX | Turtle Cameron Chief Business Officer | 50,699 | $0 | 0 (Direct) | View |
| 2021-01-26 Equity Swap | 2021-01-28 7:00 pm | N/A N/A | Eidos Therapeutics Inc. | EIDX | Sinha Uma Chief Scientific Officer | 303,525 | $0 | 0 (Direct) | View |
| 2020-10-27 Gift | 2021-01-28 7:00 pm | N/A N/A | Eidos Therapeutics Inc. | EIDX | Sinha Uma Chief Scientific Officer | 3,000 | $0 | 0 (Direct) | View |
| 2021-01-11 Exercise | 2021-01-13 4:05 pm | N/A 2028-05-06 | Eidos Therapeutics Inc. | EIDX | Valle Franco Senior Vice President, Finance | 3,247 | $0 | 50,447 (Direct) | View |
| 2021-01-11 Exercise | 2021-01-13 4:05 pm | N/A N/A | Eidos Therapeutics Inc. | EIDX | Valle Franco Senior Vice President, Finance | 3,247 | $7.24 | 50,447 (Direct) | View |